{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/prostate-cancer/references/","result":{"pageContext":{"chapter":{"id":"812bede6-3d25-5e1d-ba87-ac56af0e611f","slug":"references","fullItemName":"References","depth":1,"htmlHeader":"<!-- begin field 9a3b5c59-87b7-4ae4-a8c6-9436277e5f78 --><h1>References</h1><!-- end field 9a3b5c59-87b7-4ae4-a8c6-9436277e5f78 -->","summary":null,"htmlStringContent":"<!-- begin item 741e0846-8057-45b1-beca-7e129f0d33f6 --><!-- begin field 8afee969-75c1-4b53-b904-7fee70475578 --><ul class=\"bibliography\"><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">SPC for Provera 10 mg tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"abcd84e7-3346-4d89-9af7-ac07017f9a87\">https://www.medicines.org.uk/emc</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.medicines.org.uk/emc/medicine/29627\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"02a43323-0214-4b50-baea-ac07017f9a9b\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">SPC for Cyprostat&#160;50mg</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd</span>. <span rel=\"bibo:Website\"><a href=\"http://www.medicines.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"18fc659b-19f4-4785-a261-ac05007b5da0\">http://www.medicines.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.medicines.org.uk/emc/medicine/20814\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"29c33f3c-b236-4414-b680-ac05007b5dc7\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ASCO                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">Systemic therapy in men with metastatic castration-resistant prostate cancer</span>. <em>Journal of Clinical Oncology</em> <strong><span rel=\"bibo:volume\">32</span></strong>(<span rel=\"bibo:issue\">30</span>),  3436-3452. [<span rel=\"bibo:uri\"><a href=\"http://ascopubs.org/doi/abs/10.1200/jco.2013.54.8404\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"b84094eb-e92f-49f4-91e3-ac07017f7e5c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BMJ                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Prostate cancer</span></em>. <span property=\"dc:publisher\">BMJ Best Practice</span>. <span rel=\"bibo:Website\"><a href=\"http://www.bestpractice.bmj.com/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2d6cbb75-e18d-462a-9590-ac0300802ae5\">http://www.bestpractice.bmj.com</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BNF 73                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">British National Formulary</span></em>. 73rd edn. London:  <span property=\"dc:publisher\">British Medical Association and Royal Pharmaceutical Society</span>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Cancer Research UK                </span> (<span property=\"dcterms:issued\">2014</span>) <em><span property=\"dc:title\">Prostate&#160;cancer statistics</span></em>. <span property=\"dc:publisher\">Cancer Research UK</span>. <span rel=\"bibo:Website\"><a href=\"http://www.cancerresearchuk.org/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"3fce25a0-db30-440f-a7c4-ac05007b5e6a\">http://www.cancerresearchuk.org</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    EAU                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Prostate cancer</span></em>. <span property=\"dc:publisher\">European Association of Urology</span>. <span rel=\"bibo:Website\"><a href=\"http://www.uroweb.org/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"b84aca61-0b95-4aa4-8bf2-ac0300802a3c\">http://www.uroweb.org</a></span> [<span rel=\"bibo:uri\"><a href=\"http://uroweb.org/guideline/prostate-cancer\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"a2409aa6-b7bf-4103-b7a7-ac0300802a9d\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Neal, D.                </span> (<span property=\"dcterms:issued\">2010</span>) <bookchapter>Malignant diseases of the urinary tract</bookchapter>.                <text> In: </text>                <span property=\"bibo:editorList\">                    Warrell, D.A., Cox, T.M. and Firth, J.D.                </span><text> (Eds.)</text> <em><span property=\"dc:title\">Oxford textbook of medicine</span></em>. Oxford:  <span property=\"dc:publisher\">Oxford University Press</span>,  4162-4173.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2005a</span>) <em><span property=\"dc:title\">High-intensity focused ultrasound for prostate cancer: guidance (NICE interventional procedure guidance 118)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2140f50b-dbcf-46f5-b019-ac050079962f\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://guidance.nice.org.uk/IPG118/Guidance/pdf/English\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"8d778b40-2c61-44db-9c13-ac0500799661\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2005b</span>) <em><span property=\"dc:title\">Cryotherapy for recurrent prostate cancer: guidance (NICE interventional procedure guidance 119)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"268f1407-73a2-4cf4-9433-ac05005e18de\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://guidance.nice.org.uk/IPG119/Guidance/pdf/English\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"2facf62c-ea72-4ccc-b6da-ac05005e1906\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2005c</span>) <em><span property=\"dc:title\">Cryotherapy as a primary treatment for prostate cancer: guidance (NICE interventional procedure guidance 145)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"fee1980b-7ff7-4f23-8eba-ac0500791613\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://guidance.nice.org.uk/IPG145/Guidance/pdf/English\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"b1dc8073-1896-4d3f-8aae-ac050079163a\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2006</span>) <em><span property=\"dc:title\">High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer: guidance (NICE interventional procedure guidance 174)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"6005dab9-47b4-4c6a-bf3e-ac05006ba843\">http://www.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2008</span>) <em><span property=\"dc:title\">Metastatic spinal cord compression: diagnosis and management of adults at risk of and with metastatic spinal cord compression (NICE guideline)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Clinical Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"572be81e-2720-4961-b40c-ac050076221a\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.nice.org.uk/Guidance/CG75/NiceGuidance/pdf/English\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"f97515c3-4b5c-4bc2-880f-ac0500762240\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2014</span>) <em><span property=\"dc:title\">Prostate cancer: diagnosis and management</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"8677fa2e-496b-407e-8dab-ac03008029e5\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/cg175\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"0ea8a847-9a21-4c35-b177-ac0300802a0c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2015a</span>) <em><span property=\"dc:title\">Suspected cancer: recognition and referral (NICE guideline)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"67cbf098-4852-4c1f-85b7-abf000b5ccc4\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.nice.org.uk/guidance/ng12\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"e6b78696-76a3-4025-badc-abf000b5ccf1\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    National Institute for Health and Care Excellence                </span> (<span property=\"dcterms:issued\">2015b</span>) <em><span property=\"dc:title\">Quality standard: prostate cancer</span></em>. <span property=\"dc:publisher\">NICE</span>. <span rel=\"bibo:Website\"><a href=\"http://nice.org.uk/guidance/qs91\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"a0ef2db7-32ca-4570-b348-ac0300802eaf\">http://nice.org.uk/guidance/qs91</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2015c</span>) <em><span property=\"dc:title\">Lower urinary tract symptoms in men: management</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care&#160;Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"3c1cd168-f6c8-41ec-8d4a-ac05007b5e41\">http://www.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016a</span>) <em><span property=\"dc:title\">Suspected cancer (QS124)</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"https://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"1dfd4306-be61-43f1-aef8-ac0300665032\">https://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/qs124\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"065b5263-bbf0-4e08-8237-ac030066504c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016b</span>) <em><span property=\"dc:title\">Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"https://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"bb35bca5-c3ae-4608-a098-ac0300815774\">https://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/ta387\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"01df99f4-c775-47d1-9eeb-ac030081578f\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016c</span>) <em><span property=\"dc:title\">Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://nice.org.uk/guidance\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"94bf08d1-5dd2-4886-93c3-ac0300815852\">http://nice.org.uk/guidance</a></span> [<span rel=\"bibo:uri\"><a href=\"http://nice.org.uk/guidance/ta377\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"b22a4af4-0b81-4e73-9684-ac0300815889\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016d</span>) <em><span property=\"dc:title\">Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://nice.org.uk/guidancce\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"076b0798-eb0f-49af-9991-ac03008158d3\">http://nice.org.uk/guidancce</a></span> [<span rel=\"bibo:uri\"><a href=\"http://nice.org.uk/guidance/ta412\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"87367cf1-ad83-4e2d-a6b2-ac0300815933\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016e</span>) <em><span property=\"dc:title\">Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"https://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"3c63b3f1-195f-4689-a58c-ac030081573c\">https://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/guidance/ta391\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"0b24f044-4b9c-410f-890d-ac0300815756\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://nice.org.uk/guidance\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"c4d0aead-a8cf-4ebf-8414-ac03008157c0\">http://nice.org.uk/guidance</a></span> [<span rel=\"bibo:uri\"><a href=\"http://nice.org.uk/guidance/ta259\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"9a6f808f-dd42-459c-bac1-ac03008157ff\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    PHE                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing</span></em>. <span property=\"dc:publisher\">Public Health England</span>. <span rel=\"bibo:Website\"><a href=\"https://www.gov.uk/government/publications\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"df8aa1ae-c279-4b8a-8c73-ac0300802dba\">https://www.gov.uk/government/publications</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"4bd76eb6-04f4-4a79-b134-ac0300802e43\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Stacey, R. and Green, J.T.                </span> (<span property=\"dcterms:issued\">2014</span>) <em><span property=\"dc:title\">Radiation-induced small bowel disease: latest developments and clinical guidance</span></em>. [<span rel=\"bibo:uri\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871275\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"ab63d231-03ec-44cb-aba3-ac03008155d3\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    UKNSC                </span> (<span property=\"dcterms:issued\">2015</span>) <em><span property=\"dc:title\">Screening for prostate cancer review 2015 update</span></em>. <span property=\"dc:publisher\">UK National Screening Committee</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"5e725bea-c2a2-49b4-903b-ac030082c80f\">http://www.gov.uk</a></span>            </span></li></ul><!-- end field 8afee969-75c1-4b53-b904-7fee70475578 --><!-- end item 741e0846-8057-45b1-beca-7e129f0d33f6 -->","topic":{"id":"2ab521f2-aa56-5e1e-b28e-fc4d637a303c","topicId":"1506c25e-8998-42e4-82c0-6b38dc3a1e9f","topicName":"Prostate cancer","slug":"prostate-cancer","lastRevised":"Last revised in October 2017","chapters":[{"id":"324faedd-14d8-5d99-8059-d9428da432ea","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"276607b5-8522-5d5e-86f1-d9be97d83a94","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"df8fe922-4f04-5594-b4a9-fc0935cf3b16","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d95f0cd5-43fd-5950-b45a-5d312e16b3e3","slug":"changes","fullItemName":"Changes"},{"id":"dc0f462f-4d9f-503f-ae6e-64aa386af1e8","slug":"update","fullItemName":"Update"}]},{"id":"fb4bea73-b877-5f11-9f5e-f4b1a776c6ab","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d9df68e4-4518-5224-b388-b610695e181f","slug":"goals","fullItemName":"Goals"},{"id":"cbda6200-7ae0-5f80-b984-4f2e0d78d4de","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b6c612ea-8423-5c36-abab-32784d6ed762","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4909e587-a937-5829-873f-b3e02e5c8a36","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b3baf3db-45b6-5fd4-94e3-cbbaf8d70bd9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d0703c17-2896-5c8e-a091-a6024da2508d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b6a5e49a-643a-5e4a-a980-dc835d73c66d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"7fb66c84-18e5-52f1-b7ef-daf96c4f903c","slug":"definition","fullItemName":"Definition"},{"id":"ae301838-d2bd-55ed-a057-844f73f6942a","slug":"causes","fullItemName":"Causes"},{"id":"5656e958-479a-5103-96a1-2b0d6c62c156","slug":"prevalence","fullItemName":"Prevalence"},{"id":"49f9ec22-1376-50e7-8891-e6050fbb5069","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"cf644b3b-5878-59e9-9641-63847a7f0cb5","slug":"prognosis","fullItemName":"Prognosis"},{"id":"511452bc-068d-5f51-b489-9e89b4396cd2","slug":"complications","fullItemName":"Complications"}]},{"id":"6c4ca641-81fa-53e0-8562-431396232bd7","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7e53b66c-2f4f-500c-a8c0-9092cbce65bf","slug":"overview","fullItemName":"Overview"},{"id":"5e184056-05a4-5462-80be-51f03c9c94a2","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"5f6622b7-59bf-51f5-b413-1f0ec1a4b8d1","slug":"psa-testing","fullItemName":"PSA testing"},{"id":"30dc380e-addd-57b7-a015-a1b250c58b3c","slug":"digital-rectal-examination","fullItemName":"Digital rectal examination"},{"id":"509e34cf-6a18-526e-a3f0-d219fa4030de","slug":"when-to-refer","fullItemName":"When to refer"},{"id":"8fdd4166-47a6-5d1b-b573-bb1ab5d09da8","slug":"confirming-diagnosis-in-secondary-care","fullItemName":"Confirming diagnosis in secondary care"}]},{"id":"9dc72b4c-cd09-5f23-b45c-6d0306fa66dc","fullItemName":"Management","slug":"management","subChapters":[{"id":"56e2a92b-f611-57ed-91c6-f6672b72750f","slug":"management","fullItemName":"Scenario: Management"},{"id":"6cf2bc9c-e41d-5e71-b490-a48c7fa4a38b","slug":"complications-adverse-effects","fullItemName":"Scenario: Complications and adverse effects"}]},{"id":"742a5289-99d4-5d61-a8c9-7fc8409f0f23","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"5009abfd-1456-55b3-844d-23b74552f90c","slug":"medroxyprogesterone-acetate","fullItemName":"Medroxyprogesterone acetate"},{"id":"80712d44-9544-56aa-aa10-d4cd640429de","slug":"cyproterone-acetate","fullItemName":"Cyproterone acetate"}]},{"id":"7bed120a-c6b8-5f7e-941d-751749f78c0e","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1c5c0083-b591-5115-8039-cdc5113cc070","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6562ed52-3498-5877-b63d-7bb4a7b2656a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e27e1bd1-e689-5a6c-a6e5-36b9fcad98a3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1d7864fd-9f5c-5976-a1b8-9df023b04f7e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e6798a57-1676-5675-b1a1-50a69534adff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"67b2f477-e9ac-5da3-a8ab-5544ec9d70f3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"812bede6-3d25-5e1d-ba87-ac56af0e611f","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}